论文部分内容阅读
一、国内现状和存在的差距 经过四十多年的建设和发展,我国医药工业已形成一个具有一定规模和生产能力的科研与生产体系,目前全行业拥有工商企业2500多家,正式职工约150万人,各类专业的工程技术人员15.8万人,抗感染药、解热镇痛药、心血管系统药、呼吸系统用药、中枢神经系统用药、抗肿瘤药、抗寄生虫药、维生素类药、计划生育及激素类药等二十四大类产品基本齐全;1990年原料药产量11.03万吨,仅次于美国。四十多年来主要依靠我国自己的科技力量,先后研制与开发成功1300多个品种,实现了药品基本自给;但与先进的发达国家相比,最突出的问
First, the gap between the status quo and the existing After more than 40 years of construction and development, China’s pharmaceutical industry has formed a scientific research and production system of a certain scale and production capacity, the entire industry has more than 2,500 industrial and commercial enterprises, formal staff of about 150 Million, all kinds of professional engineering and technical personnel 158,000 people, anti-infectives, antipyretic analgesics, cardiovascular system drugs, respiratory system drugs, central nervous system drugs, anti-tumor drugs, anti-parasitic drugs, vitamin drugs , Family planning and hormonal drugs and other twenty-four major categories of products are basically complete; in 1990 the output of raw materials 110,300 tons, second only to the United States. Over the past 40 years, it has mainly relied on China’s own scientific and technological strength and successively developed and successfully developed more than 1,300 varieties, thus realizing the basic self-sufficiency of medicines. However, compared with the advanced countries, the most prominent question